Barrington Research Reiterates “Outperform” Rating for DENTSPLY SIRONA (NASDAQ:XRAY)

DENTSPLY SIRONA (NASDAQ:XRAY)‘s stock had its “outperform” rating reaffirmed by research analysts at Barrington Research in a note issued to investors on Tuesday,Benzinga reports. They presently have a $14.00 target price on the medical instruments supplier’s stock. Barrington Research’s price target suggests a potential upside of 22.48% from the stock’s current price.

A number of other brokerages have also issued reports on XRAY. Wall Street Zen lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Saturday, October 18th. Mizuho set a $13.00 price objective on shares of DENTSPLY SIRONA in a report on Friday, November 7th. Stifel Nicolaus set a $13.00 price objective on shares of DENTSPLY SIRONA in a research report on Thursday, November 6th. Barclays started coverage on DENTSPLY SIRONA in a research report on Monday, December 8th. They set an “underweight” rating and a $12.00 target price on the stock. Finally, Robert W. Baird dropped their price target on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a research report on Tuesday. Two research analysts have rated the stock with a Buy rating, ten have given a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Reduce” and a consensus price target of $15.15.

DENTSPLY SIRONA Trading Up 0.5%

DENTSPLY SIRONA stock opened at $11.43 on Tuesday. DENTSPLY SIRONA has a 52 week low of $9.85 and a 52 week high of $20.59. The company has a debt-to-equity ratio of 1.36, a quick ratio of 0.99 and a current ratio of 1.47. The firm has a market capitalization of $2.28 billion, a PE ratio of -2.59, a PEG ratio of 0.83 and a beta of 1.01. The business’s 50-day simple moving average is $11.69 and its 200-day simple moving average is $13.65.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 earnings per share for the quarter, missing the consensus estimate of $0.45 by ($0.08). The business had revenue of $904.00 million for the quarter, compared to the consensus estimate of $900.33 million. DENTSPLY SIRONA had a negative net margin of 24.34% and a positive return on equity of 17.10%. DENTSPLY SIRONA’s revenue for the quarter was down 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.50 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. Equities research analysts forecast that DENTSPLY SIRONA will post 1.84 earnings per share for the current year.

Insider Transactions at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier sold 82,200 shares of DENTSPLY SIRONA stock in a transaction on Monday, December 8th. The shares were sold at an average price of $11.14, for a total transaction of $915,708.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.50% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Brooklyn Investment Group bought a new stake in DENTSPLY SIRONA in the first quarter valued at about $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in shares of DENTSPLY SIRONA in the 1st quarter valued at approximately $26,000. Trust Co. of Toledo NA OH bought a new position in DENTSPLY SIRONA during the 2nd quarter worth approximately $27,000. Parkside Financial Bank & Trust grew its holdings in DENTSPLY SIRONA by 620.6% during the second quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock valued at $27,000 after purchasing an additional 1,477 shares during the period. Finally, Huntington National Bank grew its holdings in DENTSPLY SIRONA by 292.9% during the third quarter. Huntington National Bank now owns 2,786 shares of the medical instruments supplier’s stock valued at $35,000 after purchasing an additional 2,077 shares during the period. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.